30 Stocks Top Picks (NOV 16-22)

Opinion about HBC-T: Nicknames it Hit By A Car like its chart. HBC is all about its real estate holdings; that's the reason you own this. Doesn't know if the current rally signals a buy. Can't predict this chart. Even consider selling it.

Opinion about MHK-N: They had a great quarter, but so did Whirlpool and the market didn't pay attention. He prefers Whirlpool.

Opinion about DOL-T: Will be affected if Trump doesn't do a deal with China, because that's where they get their stuff. That's as far as he's going to go on fundamentals; charts tell us everything we need to know. Chart shows the uptrend, and then the arc off trendline is a parabolic move. He'd bet that…

Opinion about BRB-T: (A Top Pick Jun 18/18, Up 1%) Still likes it. It's well-run. They're growing their brands and they have a big opportunity to get into cannabis beverages which will be legal in Canada in October 2019. BRB is well-positioned for this and this market could be very large.

Opinion about GC-T: Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Takeover offer. Pandemic hit hard. Solid assets, but re-opening slowed. Healthy balance sheet.

Browse a daily summary of experts opinions on stocks and stock investment information.

Opinion about FANG-Q: It comes highly recommended with a very strong growth profile. Its size is intermediate to junior. He also commented that a maximum of 10 to 15% of oil and gas companies should be in a portfolio. Utilities, a classic defensive space, would be smaller at 7 to 8% of a portfolio, and…

Opinion about PE-N: (A Top Pick Sep 01/20, Up 56.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with PE has resulted in the company being acquired by Pioneer Natural Resources. We are considering the position now closed at the last market closing price of $16.93. Combined with the previous recommendation to cover 50%, the…

Opinion about BTE-T: Has gone through lots of turmoil. Talk of selling its Eagle Ford assets. Split between Canadian heavy oil and lighter oil on one hand, and Eagle Ford shale. That sale would be a catalyst, making it a pure-play in Canada.

Opinion about VET-T: It is trading where it should. There are headwinds with European gas prices. It has struggled quite a lot but the last quarter was reasonable. You should probably sell it for something with more growth.

Opinion about SGY-T: Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research SGY is quite small at $510M, but the stock is very cheap. With a 10% dividend, a buyer (or privatization) could eliminate the dividend and use internal cash flow to pay for the whole company in about three years. But, that doesn't…

Opinion about CPG-T: Great company. Looking at the chart, big wall of resistance it just couldn't get through. Then it broke out. If you own it, hold. If it pulls back to the neckline, he'd be all over it.

Opinion about TRP-T: (A Top Pick Sep 05/24, Up 40%) This market will make anyone look good 🙂  One of the largest pipelines in NA, focused on natural gas. Strong future, as access to overseas markets will allow those markets to reduce reliance on coal, for example. We still need to source power when the…

Opinion about ENB-T: He's been cautious on the pipes. The pipeline ETF in the US is hitting RSI new lows for the year, as are a lot of the pipes in Canada (including the best-performing one, ENB). Price chart looks fine, relative strength is weak. Fine for the yield.People looking at long-life, more-utility-type assets are…

Opinion about ISC-T: (A Top Pick Feb 19/25, Up 20%) (Note the short timeframe.)  Steady business. Lots of FCF, nice dividend. Good run, but still cheap.

Opinion about CME-Q: CME Group is committed to delivering new ways to manage risk and improve efficiency. Whether that means developing product solutions to empower trading strategies, expanding access to unique data insights, seamlessly connecting siloed liquidity pools, or introducing more ways to optimize the time and capital required for world-class risk management, new opportunities…

Opinion about BAM.A-T: They own it in the Canadian portfolio. There is a big push towards alternative assets and they generate fees on and grow the quality assets they manage. This includes de-carbonization, wind and solar. It also has partnerships with data centres. They have a pretty meaningful presence in any infrastructure project around the…

Opinion about WIR.UN-T: (A Top Pick Jan 12/21, Up 48%) Great-managed REIT. Taken out.

Opinion about V-N: (A Top Pick Oct 22/24, Up 22%) Hasn't trimmed. In a portfolio, not all stocks move at the same time. Some take leadership, while others take a breather. Visa's been successful at gaining market share, inflation also helps. Trades just south of 30x PE, and analysts give it 13% growth. A stable…

Opinion about AAPL-Q: At this point, pretty fully priced. iPhone 17 seems to have a lot of traction, taking many by surprise. Lots of new features, plus it's in a replacement cycle. If you own it, write some short-dated, 1- or 2-week calls with a strike price of ~$265-270. Not much runway left.

Opinion about MSFT-Q: (A Top Pick Apr 15/24, Up 24%) Steady 10-15% earnings growth, and a lot flows through to FCF. Can easily fund a lot of the AI buildout. Can't actually build fast enough to get the GPUs they need to grow the business, so this might be an issue. Azure still growing almost…

Opinion about ECL-N: Good time to buy. 

Opinion about NTR-T: (A Top Pick Oct 09/24, Up 28%) He'd buy this one today. Agriculture is a long-term theme, and this is one of the best names out there. Will be more volatile than a name like WMT, so perhaps you only want a 3% position total. Buy 1% today, and look for a…

Opinion about SYK-N: He hasn't seen valuations like this since 2020 briefly and 1993. Their big growth driver is orthopedics with robot-assisted surgeries, with growth expected to double over 5 years; robots account for roughly 45% of their orthopedics business. (Analysts’ price target is $429.76)

Opinion about BMY-N: Has never been this cheap. Has high hopes for their new central nervous system drug; it if doesn't work, he will sell BMY.

Opinion about BIP-N: Not really affected by tariffs. In the private equity area. Probably the fastest-growing part of the business. Will continue to be quite a hot area. He prefers BN.

Opinion about SPGI-N: (A Top Pick Jun 13/24, Up 20%) All its businesses are very profitable, with operating margins in 50% range. Recurring revenue stream from subscriptions. Great businesses, very scalable. 

Opinion about H-T: Likes the regulated utilities. 

Opinion about T-T: His firm buys market leaders in sectors that are being positively revalued. Multiple in this sector has been contracting for a long time. Big question is where does revenue come from? Very hard to turn around a stock in a weak sector that's underperforming. If you can't rally in a bull market, what…

Opinion about BCE-T: (A Top Pick Nov 12/24, Down 6%) Still sees it as a pretty asset-rich company. Dividend's been reset. Stock has attracted a few upgrades. Bounce from $29 to $34 is already pretty significant. Happy to buy down here where nobody wants it. It's one of those durable companies, need for telecommunications is…